Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.
2.

Influence of a modified propofol equilibration rate constant (k(e0)) on the effect-site concentration at loss and recovery of consciousness with the Marsh model.

Seo JH, Goo EK, Song IA, Park SH, Park HP, Jeon YT, Hwang JW.

Anaesthesia. 2013 Dec;68(12):1232-8. doi: 10.1111/anae.12419. Epub 2013 Sep 14.

3.

Predictive ability of propofol effect-site concentrations during fast and slow infusion rates.

Sepúlveda PO, Cortínez LI, Recart A, Muñoz HR.

Acta Anaesthesiol Scand. 2010 Apr;54(4):447-52. doi: 10.1111/j.1399-6576.2009.02183.x. Epub 2009 Dec 14.

PMID:
20003124
4.
5.

Clinical evaluation of two Ke0 in the same pharmacokinetic propofol model: study on loss and recovery of consciousness.

Simoni RF, Esteves LO, Miziara LE, Cangiani LM, Alves GG, Romano AL, Hansen PÚ, Vianna PT.

Rev Bras Anestesiol. 2011 Jul-Aug;61(4):397-408. doi: 10.1016/S0034-7094(11)70048-4. English, Multiple languages.

6.

Comparison of plasma compartment versus two methods for effect compartment--controlled target-controlled infusion for propofol.

Struys MM, De Smet T, Depoorter B, Versichelen LF, Mortier EP, Dumortier FJ, Shafer SL, Rolly G.

Anesthesiology. 2000 Feb;92(2):399-406.

PMID:
10691226
7.

Targeting effect compartment or central compartment concentration of propofol: what predicts loss of consciousness?

Wakeling HG, Zimmerman JB, Howell S, Glass PS.

Anesthesiology. 1999 Jan;90(1):92-7.

PMID:
9915317
8.
9.

Individual effect-site concentrations of propofol at return of consciousness are related to the concentrations at loss of consciousness and age in neurosurgical patients.

Nunes CS, Ferreira DA, Antunes L, Lobo F, Santos IA, Amorim P.

J Clin Anesth. 2009 Feb;21(1):3-8. doi: 10.1016/j.jclinane.2008.06.011.

PMID:
19232933
10.

Study of the time course of the clinical effect of propofol compared with the time course of the predicted effect-site concentration: Performance of three pharmacokinetic-dynamic models.

Coppens M, Van Limmen JG, Schnider T, Wyler B, Bonte S, Dewaele F, Struys MM, Vereecke HE.

Br J Anaesth. 2010 Apr;104(4):452-8. doi: 10.1093/bja/aeq028. Epub 2010 Feb 26.

11.
12.

Required decrement time to predict time of awaking in effect-site concentration can be estimated by using that in predicted blood concentration displayed on the commercial TCI pump.

Kunisawa T, Onodera Y, Kurosawa A, Sasakawa T, Hanada S, Iwasaki H.

J Anesth. 2010 Dec;24(6):972-3. doi: 10.1007/s00540-010-1024-0. Epub 2010 Oct 10. No abstract available.

PMID:
20936483
13.

Target-controlled infusion of propofol induction with or without plasma concentration constraint in high-risk adult patients undergoing cardiac surgery.

Macquaire V, Cantraine F, Schmartz D, Coussaert E, Barvais L.

Acta Anaesthesiol Scand. 2002 Sep;46(8):1010-6.

PMID:
12190804
14.

Clinical variables related to propofol effect-site concentrations at recovery of consciousness after neurosurgical procedures.

Nunes CS, Ferreira DA, Antunes L, Amorim P.

J Neurosurg Anesthesiol. 2005 Apr;17(2):110-4.

PMID:
15840999
15.

Nervus medianus evoked potentials and bispectral index during repeated transitions from consciousness to unconsciousness.

Rundshagen I, Mast J, Mueller N, Pragst F, Spies C, Cortina K.

Br J Anaesth. 2008 Sep;101(3):366-73. doi: 10.1093/bja/aen186. Epub 2008 Jun 27.

16.

A novel technique to determine an 'apparent ke0 ' value for use with the Marsh pharmacokinetic model for propofol.

Thomson AJ, Nimmo AF, Engbers FH, Glen JB.

Anaesthesia. 2014 May;69(5):420-8. doi: 10.1111/anae.12596.

17.

The effect of aminophylline on loss of consciousness, bispectral index, propofol requirement, and minimum alveolar concentration of desflurane in volunteers.

Turan A, Kasuya Y, Govinda R, Obal D, Rauch S, Dalton JE, Akça O, Sessler DI.

Anesth Analg. 2010 Feb 1;110(2):449-54. doi: 10.1213/ANE.0b013e3181c6be7e. Epub 2009 Dec 2.

PMID:
19955506
18.

Bi-spectral index, entropy and predicted plasma propofol concentrations with target controlled infusions in Indian patients.

Puri GD, Mathew PJ, Sethu Madhavan J, Hegde HV, Fiehn A.

J Clin Monit Comput. 2011 Oct;25(5):309-14. doi: 10.1007/s10877-011-9309-x. Epub 2011 Oct 1.

PMID:
21964767
19.

Effects of dexmedetomidine on performance of bispectral index as an indicator of loss of consciousness during propofol administration.

Chen Z, Shao DH, Hang LH.

Swiss Med Wkly. 2013 Mar 14;143:w13762. doi: 10.4414/smw.2013.13762.

20.

[Reevaluation of the time course of the effect of propofol described with the Schnider pharmacokinetic model].

Sepúlveda PO, Mora X.

Rev Esp Anestesiol Reanim. 2012 Dec;59(10):542-8. doi: 10.1016/j.redar.2012.07.019. Epub 2012 Oct 4. Spanish.

PMID:
23040653
Items per page

Supplemental Content

Write to the Help Desk